MedicalCV to invest fresh funds in ablation system:
This article was originally published in Clinica
Executive Summary
MedicalCV, of Minneapolis, Minnesota, has raised $13.6m through the sale of convertible preference stock and common stock warrants. It has also converted $4.4m of debt into such securities. The company says it the proceeds will fund further development of its Atrilaze surgical ablation system, and repay about $0.5m worth of convertible notes.